The development of seaweed-derived bioactive compounds for use as prebiotics and nutraceuticals using enzyme technologies by Charoensiddhi, Suvimol & Conlon, Michael A
Archived at the Flinders Academic Commons: 
http://dspace.flinders.edu.au/dspace/ 
‘This is the peer reviewed version of the following article: 
Charoensiddhi, S., Conlon, M. A., Franco, C. M. M., & 
Zhang, W. (2017). The development of seaweed-derived 
bioactive compounds for use as prebiotics and 
nutraceuticals using enzyme technologies. Trends in Food 
Science & Technology, 70, 20–33. https://
doi.org/10.1016/j.tifs.2017.10.002 
which has been published in final form at 
http://dx.doi.org/10.1016/j.tifs.2017.10.002
© 2017 Elsevier. This manuscript version is made available 
under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/ 
Accepted Manuscript
The development of seaweed-derived bioactive compounds for use as prebiotics and
nutraceuticals using enzyme technologies




To appear in: Trends in Food Science & Technology
Received Date: 19 May 2017
Revised Date: 28 September 2017
Accepted Date: 9 October 2017
Please cite this article as: Charoensiddhi, S., Conlon, M.A., Franco, C.M.M., Zhang, W., The
development of seaweed-derived bioactive compounds for use as prebiotics and nutraceuticals using
enzyme technologies, Trends in Food Science & Technology (2017), doi: 10.1016/j.tifs.2017.10.002.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all















The development of seaweed-derived bioactive compounds for use as prebiotics and 1 
nutraceuticals using enzyme technologies 2 
 3 
Suvimol Charoensiddhi a,b, Michael A. Conlon c, Christopher M.M. Franco a,b, Wei Zhang a,b,* 4 
 5 
a Centre for Marine Bioproducts Development, College of Medicine and Public Health, 6 
Flinders University, Bedford Park, South Australia 5042, Australia 7 
b Medical Biotechnology, College of Medicine and Public Health, Flinders University, 8 
Bedford Park, South Australia 5042, Australia 9 
e-mail: suvimol.charoensiddhi@flinders.edu.au 10 
e-mail: chris.franco@flinders.edu.au  11 
e-mail: wei.zhang@flinders.edu.au 12 
 13 
c CSIRO Health and Biosecurity, Kintore Avenue, Adelaide, South Australia 5000, Australia 14 
e-mail: Michael.Conlon@csiro.au  15 
 
16 























Abstract  26 
Background: Seaweeds are a large and diverse group of photosynthetic macro-algae found 27 
across the world’s oceans. There is a growing recogniti n that they are important sources of 28 
bioactive compounds with a variety of biological activities that could potentially contribute to 29 
functional food and nutraceutical industries.  30 
Scope and approach: The complex structure and distinctive components of eaweed cell 31 
walls, which differ significantly from terrestrial plants, presents a major challenge for the 32 
effective extraction of bioactive compounds from inside the cells. Enzyme technologies have 33 
been used to improve the extraction, hydrolysis, and structure modification efficiently with a 34 
high degree of environmental sustainability. This review critically analyses the advances, 35 
challenges, and future directions in applying enzyme technologies to improve the extraction 36 
and processing of bioactive compounds from seaweeds an  their potential applications in 37 
functional foods and nutraceuticals.  38 
Key findings and conclusions: Different enzymatic processes have been demonstrated to (1) 39 
assist the extraction by breaking down the seaweed c ll walls, and (2) degrade or hydrolyse 40 
macromolecules including polysaccharides and proteins. These enzymatic processes improve 41 
the yield and recovery of bioactive compounds and ehance their biological properties with 42 
regard to prebiotic, antioxidant, ACE inhibitory, anti-inflammatory, and antiviral effects. 43 
Seaweed-derived bioactive compounds from these processes present significant new 44 
opportunities in developing novel food applications. The current food regulations and safety 45 
requirements for seaweeds and their products are addressed for commercial product 46 
development.  47 
Key words Biological properties; Enzymatic process; Food safety; Functional food; 48 
















1. Background 51 
Marine macroalgae or seaweeds constitute approximately 25,000-30,000 species 52 
(Santos et al., 2015), with a great diversity of forms and sizes. They can be categorized into 53 
different taxonomic groups reflecting their pigmentation, including red algae 54 
(Rhodophyceae), brown algae (Phaeophyceae), and green algae (Chlorophyceae) (Mohamed 55 
et al., 2012). Seaweeds have become an appealing source f r commercial applications as they 56 
have fast growth rates and do not require arable land, fresh water, or even fertilizer when 57 
compared with terrestrial plants (Lorbeer et al., 2013). The cultivation of seaweeds has been 58 
growing rapidly and is now practiced in about 50 countries, and 28.5 million tonnes of 59 
seaweeds and other algae were harvested in 2014 to be used for direct consumption, or as a 60 
starting material for the production of food, hydrocolloids, fertilizers, and other purposes 61 
(FAO, 2016). Recently, the annual global production of alginate, carrageenan, and agar 62 
which are the most important seaweed hydrocolloids for various applications across the food, 63 
pharmaceutical, and biotechnology industries has rech d 100,000 tonnes and a gross market 64 
value just above USD 1.1 billion (Rhein-Knudsen et al., 2015).  65 
Seaweeds also contain a great variety of structurally diverse bioactive metabolites not 66 
produced by terrestrial plants (Gupta and Abu-Ghannam, 2011). Seaweeds are rich in 67 
carbohydrates, proteins, polyunsaturated fatty acids (PUFAs) including omega-3 fatty acids, 68 
and minerals as well as polyphenols, pigments (chlorophylls, fucoxanthins, phycobilins), and 69 
mycosporine-like amino acids (MAAs). These compounds possess various biological 70 
functions including antioxidant, anti-HIV, anticancer, antidiabetic, antimicrobial, 71 
anticoagulant, antivirus, anti-tumor, anti-inflammatory, immunomodulatory, prebiotic and 72 
cholesterol lowering effects (Holdt and Kraan, 2011). Although seaweed bioactive 73 
compounds are attractive for commercialisation in different functional food and nutraceutical 74 















The industrial use of enzymes to extract natural comp unds from terrestrial plants for 76 
food and nutraceutical purposes has been developed and reported as a promising technology 77 
with a number of benefits such as saving process time and energy and improving the 78 
reproducible extraction process at the commercial sc e (Puri et al. 2012). However, the 79 
efficiency of enzymatic extraction procedures for the retrieval of active compounds from 80 
seaweeds may be inhibited by the more complex and heterogeneous structure and 81 
composition of seaweed cell walls in comparison to plants, which have a cell wall mostly 82 
consisting of cellulose and hemicellulose.  83 
The main cell wall and storage polysaccharides of seaweeds vary with taxonomy. The 84 
structural polysaccharides of green seaweeds are sulphated polysaccharides, such as ulvans 85 
and sulphated galactans, xylans, and mannans, while the main storage polysaccharide is 86 
starch. Brown seaweeds contain laminarins as the storage polysaccharide, and the main cell 87 
walls are composed of alginic acids, fucoidans, andsargassans. On the other hand, red 88 
seaweed cell walls consist of agars, carrageenans, xylans, water-soluble sulphated galactans, 89 
and porphyrins (mucopolysaccharides), and the main storage polysaccharide is floridean 90 
starch (amylopectin-like glucan) (Mišurcová, 2012; Kraan, 2012). This is further complicated 91 
by a tightly-integrated network of biopolymers in seaweed cell walls, mainly 92 
polysaccharides, that are associated with proteins, proteoglycans, polymeric phenols, and 93 
various bound ions including calcium and potassium (Jeon et al., 2012; Synytsya et al., 94 
2015). An example of the structure model of a brown seaweed cell wall is shown in Fig. 1. In 95 
addition, marine algae have adapted to salty enviroments, unlike land plants. Charoensiddhi 96 
et al. (2016b) reported that salt buffers significantly reduced the extraction efficiency of 97 
carbohydrates from brown seaweed, compared with pure water. This may be due to the 98 
ability of pure water to cause an osmotic shock and the rapid influx of water into seaweed 99 















high salt content in seaweeds may inhibit enzyme-assisted extraction processes, particularly 101 
those requiring buffer systems.  102 
This review aims to critically analyse the potential role of enzyme technology in 103 
assisting with the extraction and digestion of bioactive compounds from seaweeds, and to 104 
understand the advantages, limitations, challenges, and future development directions in the 105 
application of the seaweed-derived ingredients in functional food products and nutraceuticals.  106 
 107 
2. Seaweed bioactive compounds and their potential as functional foods and 108 
nutraceuticals 109 
Carbohydrates account for the majority of seaweed biomass. Polysaccharides and 110 
oligosaccharides have therefore been the key focus f many studies looking at seaweed-111 
derived compounds. Aside from those, phenolic compounds and proteins from seaweeds have 112 
also been widely studied as potential functional ingredients. Therefore, these three classes 113 
will be the main focus of this review.  114 
2.1. Polysaccharides  115 
From an economic perspective, seaweed polysaccharides are the most important products 116 
produced from seaweeds (Michalak and Chojnacka, 2015). As the major components in 117 
seaweeds, polysaccharides account for up to 76% of the dry weight (DW) (Holdt and Kraan, 118 
2011). Seaweeds contain a high total dietary fibre content: 10-75% for brown seaweed, 10-119 
59% for red seaweed, and 29-67% for green seaweed. S aweeds are particularly rich in 120 
soluble dietary fibre, which accounts for 26-38%, 9-37%, and 17-24% in brown, red, and 121 
green seaweed, respectively (de Jesus Raposo et al., 2016). Most of these polysaccharides can 122 
be fermented by gut microbiota, which may provide a he lth benefit to humans through a 123 
prebiotic effect (O’Sullivan et al., 2010), which will be discussed in more detail later. 124 















antibacterial, and immunological activity. These include fucoidans (L-fucose and sulphate 126 
ester groups) from brown seaweeds, agars and carrageen ns (sulphated galactans) from red 127 
seaweeds, and ulvans (sulphated glucuronoxylorhamnans) and other sulphated glycans from 128 
green seaweeds (Synytsya et al., 2015).  129 
2.2. Phenolic compounds  130 
Phlorotannins are the major phenolic compounds found in brown seaweeds, constituting up to 131 
14% of dry seaweed biomass, while other phenolic compounds are found at lower levels in 132 
some red and green seaweeds. Phlorotannins are highly ydrophilic components formed by 133 
the polymerization of phloroglucinol (1,3,5-trihydroxybenzene) monomer units with a wide 134 
range of molecular weights between 126 Da and 650 kDa. They can be categorized into four 135 
groups based on their linkages which are fuhalols and phlorethols (ether linkage), fucols 136 
(phenyl linkage), fucophloroethols (ether and phenyl linkage), and eckols (dibenzodioxin 137 
linkage) (Li et al., 2011). Phlorotannins have been xplored as functional food ingredients 138 
with many biological activities such as antioxidant, anti-inflammatory, antidiabetic, anti-139 
tumor, antihypertensive, and antiallergic activities (Freitas et al., 2015). 140 
2.3. Proteins  141 
Bioactive proteins and peptides from seaweeds have been demonstrated to have antioxidant, 142 
antihypertensive, and anticoagulant activities (Harnedy and FitzGerald, 2011). Generally, a 143 
higher content of proteins is found in green and red s aweeds (10-47% of DW) compared to 144 
brown seaweeds (3-15% of DW) (Wijesekara and Kim, 2015). Important bioactive proteins 145 
from red and green seaweeds include lectin and phycobiliprotein and bioactive peptides from 146 
brown seaweeds have also been reported with angiotes n-I-converting enzyme (ACE-I) 147 
inhibitory potential (Fitzgerald et al., 2011). Additionally, most seaweed species are a rich 148 
















3. Seaweed-derived components as prebiotic sources  151 
Interest in prebiotics as functional foods has increased due to their recognised health 152 
benefits. The global prebiotics market size was over USD 2.9 billion in 2015, and continued 153 
growth is expected due to rising consumer awareness of gut health issues (Grand View 154 
Research, 2016). The term ‘prebiotic’ was introduced by Gibson et al. (2004, 2010), and 155 
defined as substrates that (1) are resistant to gastrointestinal digestion and absorption, (2) can 156 
be fermented by the microbes in the large intestine, a d (3) selectively stimulate the growth 157 
and/or activity of the intestinal microbes leading to health benefits of the host.  158 
Dietary habits influence the composition and metabolic activity of the human gut 159 
microbiota (Conlon and Bird, 2015; Flint et al., 2015). Several studies have demonstrated that 160 
a higher intake of plant dietary fibre affects the makeup of beneficial intestinal microbiota 161 
and metabolites, and inhibits the growth of potential pathogens compared with animal-162 
dominated diets richer in fat and protein (Wu et al., 2011; Claesson et al., 2012; Zimmer et 163 
al., 2012; David et al., 2014). de Jesus Raposo et al. (2016) suggested that most seaweed 164 
polysaccharides such as alginates, fucoidans, laminarins, porphyrins, ulvans, and 165 
carrageenans can be regarded as dietary fibre, as they are resistant to digestion by enzymes 166 
present in the human gastrointestinal tract, and selectively stimulate the growth of beneficial 167 
gut bacteria. Likewise, ingested polyphenols with complex structures can also reach the large 168 
intestine where they can be converted into beneficial b oactive metabolites by microbes 169 
(Cardona et al., 2013), as shown in Fig. 2, and this has been shown to occur for phlorotannins 170 
from brown seaweed (Corona et al., 2016). The fermentation of seaweed components by 171 
beneficial bacteria has also been shown to generate ben ficial metabolites such as short chain 172 
fatty acids (SCFA), particularly butyrate, acetate, and propionate (de Jesus Raposo et al., 173 
2016). The beneficial effects of SCFA on host health include protection from obesity, chronic 174 















immunity, glucose homeostasis, lipid metabolism, and ppetite regulation (Bultman, 2016; 176 
Dwivedi et al., 2016; Koh et al., 2016; Morrison et al., 2016). 177 
3.1. In vitro studies 178 
In vitro studies commonly use anaerobic human fecal fermentatio  for 24 h as a 179 
model for gut fermentation processes. Using this approach, Deville et al. (2007) reported that 180 
laminarin could stimulate the production of SCFA; esp cially butyrate and propionate. Low 181 
molecular weight (MW) polysaccharides from the red s aweed Gelidium sesquipidale caused 182 
a significant increase in populations of Bi idobacterium, as well as an increase in acetate and 183 
propionate (Ramnani et al., 2012). Rodrigues et al. (2016) obtained a similar result using an 184 
extract from the brown seaweed Osmundea pinnatifida. Charoensiddhi et al. (2016a, 2017) 185 
also demonstrated that extracts from the brown seawe d Ecklonia radiata stimulated the 186 
production of SCFA and the growth of beneficial microbes such as Bifidobacterium and 187 
Lactobacillus. In addition, Kuda et al. (2015) demonstrated that sodium alginate and 188 
laminaran from brown seaweeds inhibited the adhesion and invasion of pathogens 189 
(Salmonella Typhimurium, Listeria monocytogenes, and Vibrio parahaemolyticus) in human 190 
enterocyte-like HT-29-Luc cells. Also, the effect of intact brown seaweed Ascophyllum 191 
nodosum on piglet gut flora was studied by simulating small intestinal and caecal conditions, 192 
with antibacterial effects, especially on E.coli, and a decrease in fermentative activity being 193 
clearly observed (Dierick et al., 2010).  194 
The digestibility of seaweed components can be determin d in vitro to verify whether 195 
they are decomposed by human digestive enzymes, and thus their likelihood of reaching the 196 
large bowel and its resident microbiota. Neoagaro-oligosaccharides and glycerol galactoside 197 
from red seaweeds, for instance, have shown that they were not digestible by enzymes 198 
















3.2. In vivo studies 201 
Apart from in vitro studies, health benefits attributed to oligosaccharides and 202 
polysaccharides derived from seaweeds have been demonstrated by in vivo animal models. 203 
Most such studies have investigated prebiotic effects in rats or mice being fed a seaweed-204 
supplemented diet. Results from Liu et al. (2015) showed an increase in the abundance of 205 
beneficial gut microbes such as Bifidobacterium breve and a decrease in pathogenic bacteria 206 
such as Clostridium septicum and Streptococcus pneumonia in rats supplemented with the red 207 
seaweed Chondrus crispus. Furthermore, an increase in SCFA production and colonic growth 208 
was observed, as well as an improvement of host immunity modulation through elevation of 209 
the plasma immunoglobulin levels. Supplementation of diet with the brown seaweeds 210 
Undaria pinnatifida and Laminaria japonica has resulted in suppressed weight gain of rats, 211 
influenced the composition of gut microbial communities associated with obesity by 212 
reduction in the ratio of Firmicutes to Bacteroidetes, and reduced populations of pathogenic 213 
bacteria including Clostridium, Escherichia, and Enterobacter genera (Kim et al., 2016). The 214 
oral administration of fucoidan extracts has also been shown to reduce the inflammatory 215 
pathology associated with DSS-induced colitis in mice, indicating its potential for treating 216 
inflammatory bowel disease (Lean et al., 2015). In addition, Kuda et al. (2005) reported that 217 
rats fed a diet containing laminaran and low MW alginate suppressed the production of 218 
indole, p-cresol, and sulphide which are the putative risk markers for colon cancer. Neoagaro-219 
oligosaccharides obtained from the hydrolysis of agarose by β-agarase caused an increase in 220 
the numbers of Lactobacillus and Bifidobacterium in the feces or cecal content of mice, along 221 


















4. Current enzymatic processing of seaweed-derived bioactive compounds 226 
The selection of appropriate enzymatic processes to best suit the desired applications 227 
of the final products is a key factor to achieve an effective output. According to the present 228 
research in this area, two major enzyme-enhanced processes are normally implemented and 229 
designed in order to develop bioactive compounds from seaweeds. They are enzyme-assisted 230 
extraction and the enzymatic hydrolysis of macromolecu es. 231 
4.1 Enzyme-assisted extraction  232 
The disintegration of cell wall structures is an elementary step to facilitate the 233 
extraction of bioactive components. Various commercial enzymes, not specific to seaweeds, 234 
have been used on seaweed cell walls for the extraction of bioactive compounds from 235 
seaweeds. For instance, polysaccharides such as fucoidans are tightly associated with 236 
cellulose and proteins (Deniaud-Bouët et al., 2014), which limits their extractability from 237 
brown seaweeds. Therefore, hydrolysis of the cellulose and protein network by commercially 238 
available cellulases and proteases may enable the disintegration of the cell wall complex, thus 239 
releasing the fucoidans (or other target components).  240 
Enzymes trialled for this purpose to date include carbohydrate hydrolytic enzymes 241 
(AMG, Celluclast, Termamyl, Ultraflo, Viscozyme, etc.) and proteases (Alcalase, 242 
Flavourzyme, Kojizyme, Nutrease, Protamex, etc.) (Hardouin et al., 2014a). The results from 243 
Hardouin et al. (2014b) suggested that enzyme-assisted extraction may be a promising 244 
technique for the recovery of proteins, neutral sugars, uronic acids, and sulphate groups from 245 
green (Ulva sp.), red (Solieria chordalis), and brown (Sargassum muticum) seaweeds. The 246 
extract obtained from red seaweed using carbohydrase also showed antiviral activity. Their 247 
approach appeared to have several advantages over cnventional extraction methods, 248 
including a high extraction rate, no special solvent requirements, and savings in time and 249 















Ecklonia cava, obtained using enzyme-assisted extraction with the commercial carbohydrase 251 
Celluclast, showed potential for use as a therapeutic agent for diabetes to reduce the damage 252 
caused by hyperglycaemia-induced oxidative stress, with several potential benefits for 253 
commercialisation including its water solubility, multiple biological activities, high extraction 254 
efficiency, and non-toxicity. 255 
4.2 Enzymatic hydrolysis of macromolecules 256 
The principle motives for the structural modification of seaweed components are the 257 
enhancement of their biological activities to produce novel bioactive compounds, as well as 258 
their structural determination. Specific enzymes are generally employed in order to (1) 259 
degrade or hydrolyse high MW polysaccharides and proteins; or (2) act specifically on target 260 
molecules to modify the structure of specific functional groups.  261 
de Borba Gurpilhares et al. (2016) reported that hydrolases or lyases (alginate lyase, 262 
fucoidanase, agarase, carrageenase, etc.) and sulfotransferases or sulfatases are important 263 
seaweed-specific enzymes for preparing tailored oligosaccharides and deducing the native 264 
structure of sulphated polysaccharides. The study of Sun et al. (2014) showed that a novel κ-265 
carrageenase isolated from Pedobacter hainanensis offered an alternative approach to prepare 266 
κ-carrageenan oligosaccharides by cleaving the internal β-1,4 linkage of κ-carrageenan. The 267 
carrageenan oligosaccharides produced were reported as potential pharmaceutical products 268 
with multiple biological activities including anticoagulant, antioxidant, anti-inflammatory, 269 
and antiviral activities. In addition, alginate modifying enzymes (e.g. alginate acetylases, 270 
alginate deacetylases, alginate lyases, and mannuroan C-5-epimerases) have also been used 271 
for modification of M- and G-block and quantification purposes, for instance (Ertesvåg, 272 
2015). 273 
Food grade hydrolytic enzymes, which are capable of catalyzing seaweed-specific 274 















specific polysaccharide hydrolytic enzymes is required for digesting the parent backbone of 276 
seaweeds and to aid in the production of lower MW oligosaccharides with a variety of 277 
biological activities (Vavilala and D’Souza, 2015). Most applications of enzymatic 278 
modification are currently focused on polysaccharide degradation, but other types of enzymes 279 
such as transferase and synthase should be further dev loped in order to fulfill the application 280 
of enzyme technology for this purpose (Li et al., 2016). 281 
4.3 The effects of using enzymes for the extraction and hydrolysis of bioactive products 282 
from seaweed for prebiotic and nutraceutical applications  283 
Recent publications related to the use of enzyme-assisted extraction and enzymatic 284 
hydrolysis on seaweed substrates are summarised in Tables 1 and 2. The benefits of using 285 
commercially-available enzymes (Table 1) and seaweed-sp cific enzymes (Table 2) on the 286 
processes, as well as on the biological activities of the seaweed extracts or hydrolysates, are 287 
also presented in order to evaluate their potential for use as functional and nutraceutical 288 
sources.   289 
Most of the research thus far has focused on the use of commercially-available 290 
carbohydrate hydrolytic enzymes and proteases. Althoug  they might not hold as much 291 
promise as the development of seaweed-specific enzymes, they are convenient for use in 292 
commercial applications and are cost effective at present for industry. Also, the use of 293 
enzymes to hydrolyse cellulose and protein networks in the cell wall, in order to facilitate the 294 
liberation of other target components, can avoid excessive structural degradation common 295 
with harsh physical and chemical treatments. High MW polysaccharides, such as fucoidans of 296 
~390-2200 kDa, have shown potential to induce anticcer activity (Yang et al., 2008).  297 
On the other hand, commercial enzymes have been used to r duce the MW of target 298 
molecules in some instances. Proteases, for example, are commonly used for hydrolysis of 299 















small number of cases, to specifically digest target polysaccharides, but this is not common 301 
due to the fact that commercially available carbohydrases with activity toward seaweed-302 
specific polysaccharides remain rather rare (and expensive). Given the current lack of 303 
commercial enzymes with selectivity toward the cell wall polysaccharides of seaweeds, 304 
Sánchez-Camargo et al. (2016) suggested that pressurized liquids are currently a more 305 
effective option compared with enzymatic treatments for the recovery of phlorotannins from 306 
the seaweed Sargassum muticum. Therefore, the isolation, identification, and purification of 307 
enzymes from microorganisms that can degrade the constituents specific to seaweeds needs 308 
to be investigated, in order to improve hydrolysis efficiency.  309 
It should be noted that most publications using seawe d-specific enzymes to produce 310 
low MW seaweed fractions, such as oligosaccharides, have reported prebiotic properties. The 311 
introduction of oligosaccharides as prebiotic ingredients in functional food has increased, and 312 
a number of studies on plant polysaccharides have indicated that low MW or hydrolysed 313 
oligosaccharides have improved fermentability by gut microbial communities (Hughes et al., 314 
2007, 2008; Mussatto and Mancilha, 2007). Xu et al. (2018) also reported the potential use of 315 
β-agarase with high specific activity for extensive applications for human health in food 316 
industry. Neoagaroligosaccharide produced by this enzyme could act as non-digestible 317 
oligosaccharide prebiotics with more effective in multiple functions such as antioxidant 318 
activities and inhibition of tyrosinase activity compared with products produced by acid 319 
hydrolysis.  320 
The utilisation of enzymes for polysaccharide degradation may be intensified with 321 
physical treatments of seaweed materials before or during enzyme processes. As shown in 322 
Tables 1, this approach has shown significant improvements in the time and cost of the 323 
process, as well as the extraction yield and biologcal properties of bioactive compounds, as 324 















their substrates. Michalak and Chojnacka (2014), Kadam et al. (2015), Roselló-Soto et al. 326 
(2015), Poojary et al. (2016), and Zhu et al. (2017) reported several merits of other novel 327 
extraction processes such as electrotechnologies, microwave, ultrasound, supercritical fluid, 328 
subcritical fluid, ultra-high pressure, pressurized fluid, and autohydrolysis treatments. 329 
Therefore, the intensification of enzyme processes with these techniques could potentially 330 
yield additional benefits, particularly with regard to process efficiency for the improvement 331 
of prebiotic and other nutraceutical functions in the future, but not many studies have focused 332 
on this research area to date. 333 
 Overall, most of the available literature on the us  of enzymes for seaweed extraction 334 
and digestion suggests that the use of enzymes has a number of advantages for seaweed 335 
extraction and digestion, as they are able to yield target compounds with improved 336 
selectivity, high yields, and improved biological pro erties, while using mild conditions and 337 
non-toxic chemicals, and with reduced time, energy and process cost. These capabilities may 338 
benefit large-scale operations and improve the prospect  for using seaweeds in functional 339 
food and nutraceutical industries if some commercial and technical limitations presented on 340 
an industry scale, particularly concerning the stabili y and cost of enzymes (Puri et al., 2012), 341 
and the availability of seaweed-specific enzymes, can be overcome. 342 
4.4 Purification 343 
After the extraction and hydrolysis of bioactive products from seaweeds, the crude 344 
extract mixture may take more purification processes to further enrich bioactive compounds 345 
of interest if required. 346 
The most commonly used techniques in the purification of seaweed polysaccharides 347 
are ion-exchange chromatography (IEC), size-exclusion chromatography (SEC), affinity 348 
chromatography, and membrane filtration (Garcia-Vaquero et al., 2016). Graded precipitation 349 















is more practical method than column chromatography. In this method, the solubility of 351 
larger MW polysaccharides in ethanol or acetone is less than that of smaller MW 352 
polysaccharides, so the gradual increase in ethanol or acetone concentrations can precipitate 353 
different MW polysaccharides (Zha et al., 2012; Shi, 2016). The application of approximately 354 
67% (v/v) ethanol is a commonly practiced to precipitate the polysaccharides from the 355 
mixture (Charoensiddhi et al., 2017). In order to further purify specific polysaccharides from 356 
brown seaweeds, for instance. The separation of alginate was usually carried out using CaCl2 357 
(McHugh, 2003; Sellimi et al., 2015), while fucoidan nd laminarin were purified from the 358 
extract using membrane filtration or chromatography methods. Dialysis and ultrafiltration 359 
with different molecular weight cut-off membranes were used to separate laminarin from 360 
other polysaccharides (Rioux et al., 2010; Kadam et al., 2015). However, some problems of 361 
the ultrafiltration method were reported in term of l w yield, long time-consuming process, 362 
and inaccuracy due to non-spherical shape of polysaccharides (Shi, 2016). Anion-exchange 363 
chromatography, particularly DEAE-cellulose, Q-Sepharose Fast Flow, and Macro-Prep 364 
DEAE column is also one of the most common purification methods used for fucoidan 365 
separation based on its high anionic charges and degree of sulphation (Anastyuk et al., 2017; 366 
Wang et al., 2012a; Menshova et al., 2015; Cong et al., 2016; Dinesh et al., 2016; Imbs et al., 367 
2016). In addition, the application of SEC such as Sephacryl S-300 and TSK-GEL column 368 
allows fractionation of the fucoidan regarding to their MWs (Cong et al., 2016; Anastyuk et 369 
al., 2017).  370 
  Apart from polysaccharides, the purification of peptides is mainly based on their 371 
ionic charges, size, and hydrophobicity (Vijaykrishnaraj and Prabhasankar, 2015). SDS-372 
PAGE (sodium dodecyl sulphate-polyacrylamide gel elctrophoresis) and Gel permeation 373 
chromatography (GPC-HPLC) were the primary techniques sed to separate biologically 374 















Phlorotannin for human consumption is commonly extracted using ethanol (Wang et al., 376 
2012b) and enzyme hydrolysis (Cho et al., 2012). However, additional purification processes 377 
are required to obtain high-purity phlorotannins. Fractionation using ethyl acetate and 378 
Sephadex LH-20 column chromatography was applied to fur her purify phlorotannins (Wang 379 
et al., 2012b; Liu and Gu, 2012). In addition, Kim et al. (2014) demonstrated the purification 380 
of highly concentrated phlorotannins using macroporus adsorption resins (Diaion HP-20). 381 
The high-purity phlorotannins with 92% of recovery rate from their crude extract achieved 382 
from this chromatography method could support more application in food and pharmaceutical 383 
industries. 384 
 385 
5. Application and legislation of seaweed use in the functional food sector 386 
5.1. Seaweed and the functional food industry 387 
Increasing consumer awareness regarding the complex relationship between diet and 388 
health is resulting in demand for new functional foods that can specifically contribute to 389 
health-promotion or disease prevention, beyond providing basic nutrition (Gul et al., 2016). 390 
The global nutraceutical market, including functional foods and beverages as well as dietary 391 
supplements, was valued at around USD 250 billion in 2014, and with the rapid increase in 392 
consumer demand, is expected to reach around USD 385 billion by 2020 (Suleria et al., 393 
2015). Seaweeds are commonly used as general foodstuffs, such as flavorings for noodles, 394 
soups, and meals, as well as in snacks, salads, wrap-up vegetable, and pickled side-dishes, in 395 
Japan, China, Korea, and other coastal populations (Lee, 2008). While the recent studies on 396 
seaweed-derived functional food ingredients have shown that seaweeds are a rich source of 397 
bioactive compounds with a variety of potential health benefits and product applications 398 
(Roohinejad et al., 2017), the volume of clinical research in humans into the health-399 















Also, the functionality, bioavailability, bioaccessibility, and toxicity of the seaweed-derivd 401 
bioactive compounds when incorporated into food products still need to be ensured their 402 
compliance with standard food and nutraceutical regulations (Barba, 2017).  403 
The commercial products and patent activities on seawe d-derived bioactive 404 
compounds have increased recently. For example, polysaccharides extracted from brown 405 
seaweeds by acid extraction comprising at least 8% by weight of β-glucans, α-fucans, or their 406 
mixture have been patented for prebiotic effect and gut health improvement (O'doherty et al., 407 
2009). The Kabushiki Kaisha Yakult Honsha company from Japan has patented 408 
oligosaccharides containing fucoidan and rhamnan extracted using hydrochloric acid or 409 
trifluoroacetate from brown seaweeds such as Cladosiphon okamuranus, Chordaricles 410 
nemacystus, Hydrilla sp., and Fucus sp., and green seaweed Monostroma nitidum for 411 
prevention of gastric ulcers caused by Helicobacter pylori (Nagaoka et al., 2003). Another 412 
Japanese company Takara Shuzo and Biolsystems company from Korea have patented the 413 
isolation of oligosaccharides consisting of 3,6-anhydrogalactose under acidic conditions 414 
and/or enzymatic digestion from red seaweeds such as Gelidium, Pteocladia, and Hypnea. 415 
This compound could prevent and treat diabetes, rheumatism, and cancer (Enoki et al., 2009; 416 
Im and Kim, 2016). Apart from seaweed polysaccharides, bioactive peptides derived from 417 
seaweeds have been also developed as commercial products with angiotensin I-converting 418 
enzyme (ACE) inhibitory. The Riken Vitamin company, Tokyo, Japan has developed 419 
Wakame jelly containing peptides with antihypertensive activity. These peptides were 420 
extracted from brown seaweed Undaria pinnatifida using enzyme Protease S “Amano” from 421 
Bacillus stearothermophilus (Sato et al., 2002; Hayes and Tiwari, 2015). In addition, the 422 
antioxidant components comprising phlorotannin from brown seaweed Ascophyllum nodosum 423 
extracted using ultrasound-assisted continuous aqueous xtraction process have been also 424 















Although the reports of functional food products from seaweed-derived bioactive 426 
compounds and their related patents using enzymes to assist extraction processes and 427 
improve qualities are still not extensive, enzyme-enhanced processing could have potential 428 
for developing ingredients with various functionalities and improving the quality of bioactive 429 
compounds from seaweeds (Wijesekara and Kim, 2015). These developments could expand 430 
the breadth of product applications in the functional food market. For instance, Rhein-431 
Knudsen et al. (2015) reviewed the advantages of using enzyme-assisted extraction to 432 
enhance the value and potential applications of commercial seaweed hydrocolloids. Enzymes 433 
facilitated selective extraction at mild conditions, leading to better preserved chemical 434 
structures and functional properties, and the avoidance of contaminants. Lakmal et al. (2015) 435 
also reported that enzyme-assisted extraction is an effective method to isolate sulphated 436 
polysaccharides from seaweeds for new nutraceutical applications, as these polysaccharides 437 
exhibit many bioactivities, such as antioxidant, anti-inflammatory, anticancer, and 438 
anticoagulant effects. In addition, highly soluble o igosaccharides, produced using enzymatic 439 
hydrolysis, can be incorporated into food systems more easily and with greater functional 440 
properties (Kang et al., 2014). The potential value-enhancement of seaweed-derived food and 441 
nutraceutical ingredients using enzyme-enhanced processing is summarised in Fig. 3. 442 
5.2. Relevant regulations on seaweed functional food supplements 443 
 This review summarises the currently available knowledge on the regulations in 444 
various countries relevant to seaweed use in food and functional food supplements.  445 
In France, 21 species of macroalgae, including brown seaweeds (Ascophyllum 446 
nodosum, Undaria pinnatifida, Laminaria japonica, etc.), red seaweeds (Palmaria palmata, 447 
Porphyra umbilicalis, Gracilaria verrucosa, etc.), and green seaweeds (Ulva and 448 
Enteromorpha species), are authorized as vegetables and condiments for food consumption 449 















(Porphyra sp. and Rhodymenia palmata (L.) Grev.), and the materials derived from these 451 
species are also classified for “Generally Recognized As Safe (GRAS) food substances” in 452 
U.S. Food and Drug Administration, SCOGS-Report Number 38 (FDA, 1973). These 453 
authorizations present an opportunity for the food in ustry to include seaweeds as raw 454 
materials in food formulations and applications.  455 
However, of course these seaweeds and their products still must meet the requirement 456 
of consumer safety regulations. The maximum allowed levels of heavy metals including 457 
arsenic, lead, cadmium, tin, mercury, and iodine have been defined for edible seaweeds in 458 
most jurisdictions, but the maximum allowed bacterial levels within dried seaweeds have 459 
been defined only in France. The quality criteria and related regulations applied to seaweeds 460 
and their products are summarised in Table 3. The high levels of iodine in seaweeds appear to 461 
be gaining increasing cautionary interest. The Australian Quarantine and Inspection Service 462 
(AQIS) has now included brown seaweeds on the imported food ‘Risk List’ and are 463 
monitored at the border to ensure that only products with safe levels of iodine are imported (≤ 464 
1000 mg iodine/kg dried weight) (Food Standards Australia New Zealand; FSANZ, 2010). 465 
Also, pregnant and breastfeeding women as well as young children are advised to eat no more 466 
than one serve a week of brown seaweed (FSANZ, 2011). Bouga et al. (2015) surveyed the 467 
iodine content of seaweed and seaweed-containing products in the UK market, with the 468 
median content being 110 µg/g and 585 µg per estimated serving. They identified 26 products 469 
that may lead to an iodine intake over the upper level of European tolerable adult at 600 470 
µg/day. 471 
 The safety of seaweed consumption was also recently valuated in Belgium and 472 
Norway. Belgium’s report from the Superior Health Council (2015) conducted a risk 473 
assessment of inorganic arsenic through the consumption of edible seaweeds. They 474 















of inorganic arsenic, and the consumption of other seaweeds should be limited to 7 g dried 476 
material per day. Norway’s report from its National Institute of Nutrition and Seafood 477 
Research (NIFES) (2016) suggested that high levels of inorganic arsenic and cadmium which 478 
may limit the use of some seaweed species as food ingredients were particularly found in 479 
Norwegian brown seaweeds. However, Smith et al. (2010) compared the heavy metal content 480 
of edible seaweeds in New Zealand, including commercially available and wild-harvested 481 
seaweeds (Macrocystis pyrifera, Undaria pinnatifida, Porphyra, Ecklonia radiata, Ulva 482 
stenophylla, Durvillaea antarctica, and Hormosira banksii). None of the seaweeds studied 483 
showed significant risks with regard to heavy metals, considering the quantities that they are 484 
normally consumed. Moreover, NIFES (2016) also mentioned the risks posed by persistent 485 
organic pollutants (dioxin and polychlorinated biphenyls, etc.), toxins (pinnatoxin, 486 
aplysiatoxin, and kainic acid, etc.), anti-nutrients (polyphenols), radioactivity (radionuclides), 487 
microorganisms (bacteria associated with seaweeds and viral contagious agents), and 488 
microplastic (particle size <5 mm) contamination in seaweeds. However, a low risk of food 489 
safety hazards was observed in all of these parameters. 490 
 Apart from the aforementioned regulations applying to seaweeds and their products, 491 
some other general regulations should be considered. For example, Codex General Standard 492 
for Contaminants and Toxins in Food and Feed (Codex, 1995) provides the toxicological 493 
guidance for tolerable intake levels of contaminant for humans. The Provisional Tolerable 494 
Weekly Intake (PTWI) of inorganic arsenic, cadmium, lead, mercury, and tin are defined at 495 
0.015, 0.007, 0.025, 0.005, and 14 mg/kg body weight, respectively. Meanwhile, the FSANZ 496 
standard 1.3.4 (FSANZ, 2012) ensures that food additives (novel food and nutritive 497 
substances, etc.) added to food meet appropriate specifications for identity and purity. These 498 
substances must not contain lead at >2 mg/kg DW and arsenic, cadmium, and mercury, each 499 















of ready-to-eat foods (FSANZ, 2001) may be applied if seaweeds are used as one ingredient 501 
in products specified in this food category.  502 
 503 
6. Conclusion and future perspectives 504 
Seaweeds are a valuable source of bioactive compounds, especially with regard to their 505 
polysaccharides, phenolic compounds, and proteins. Advanced enzymatic processing is a key 506 
trend for the efficient extraction and digestion of value-added bioactive compounds from 507 
seaweeds. The potential of these compounds for a number of functional food applications is 508 
being increasingly recognised, particularly with regard to prebiotic supplements. Despite the 509 
opportunities, challenges remain in improving this technique in terms of its productivity and 510 
profitability. Enzyme intensification using other physical inputs, and enzymes with activities 511 
specific to seaweed structures, should be further investigated. Furthermore, the scaled up 512 
industrial process should be designed to support commercial implementation. The adherence 513 
of products to safety legislation are also critical and complex subjects requiring attention in 514 
order to push forward with the commercial development of seaweed ingredients for 515 
functional food and nutraceutical products. 516 
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Fig. 1 Structure model of the brown seaweed cell wall; some sulphated fucans are tightly 1004 
associated with cellulose microfibrils (flat ribbon-like shape), and they are embedded within 1005 
the alginate network. Hemicellulose components (short chain form) link with the cellulose by 1006 
hydrophobic interactions and connect with the sulphated fucans. Alginates and phenolic 1007 
compounds are associated and can form high molecular weight complexes. Proteins are 1008 
linked with sulphated fucans and covalently attached to phenolics. (adapted from Kloareg et 1009 
al., 1988; Michel et al., 2010; Deniaud-Bouët et al., 2014) 1010 
 1011 
Fig. 2 Seaweed components and their potential health benefits through prebiotic effects 1012 
 1013 
Fig. 3 Potential of using enzyme-enhanced processes to improve the value and uses of 1014 
seaweed-derived food and nutraceutical ingredients 1015 
 1016 
Table 1017 
Table 1: Studies reporting the use of c mmercially-available enzymes in the development of 1018 
seaweed bioactive compounds; B, R, and G denote brown, red, and green seaweed, 1019 
respectively. ↑ and ↓ means increase and decrease, respectively, compared to the control. 1020 
 1021 
Table 2 Studies reporting the use of seaweed-specific enzymes in the development of seaweed 1022 
bioactive compounds; B, R, and G denote brown, red, an  green seaweed, respectively. ↑ and 1023 
↓ means increase and decrease compared to control. 1024 
 1025 













Table 1: Studies reporting the use of c mmercially-available enzymes in the development of seaweed bioactive compounds; B, R, and G denote 1 
brown, red, and green seaweed, respectively. ↑ and ↓ means increase and decrease, respectively, compared to the control. 2 






E/S ratio 100 µL: 1 g, 
water, pH 4.5, 50°C, 
24 h  
Prebiotic Improved biological properties 
↑ Total SCFA and butyric acid production 
↑ Bifidobacterium and Lactobacillus  
   (In vitro human fecal fermentation 24 h) 
Charoensiddhi 









E/S ratio 60 mg: 1 g, 
water pH 5.9-6.2, 




High yield, improved biological properties 
↑ Yield; Endo-protease (2-fold)  
↑ Organic matter, neutral sugar, and protein;  
   All enzymatic extracts (up to 2-fold, 2.7-fold,  
   and 1.75-fold, respectively)   
↑ Activities against Herpes simplex virus type-1 
   - At EC50; Multiple-mix of glycosyl-hydrolases  
   (373 µg/mL) and Exo-β-1,3(4)-glucanase  
   (321µg/mL), Control (>500 µg/mL) 
↑ Free radical scavenging capacity  
    - At IC50; Endo-protease (1.8 and 12.5 mg/mL)  
    and Multiple-mix of glycosyl-hydrolases  
   (6 mg/mL), Control (>500 µg/mL) 







E/S ratio 100 mg: 1 g, 
0.2 N phosphate 
buffer, pH 6, 60°C,  
17 h 
 
ACE inhibitor High yield, improved biological properties 
↑ Yield (2.3-fold) 
↑ ACE inhibition (1.04-fold) 










E/S ratio 50 mg: 1 g, 
water, pH 4.5, 50°C, 
24 h  
Prebiotic Improved biological properties 
↑ Total SCFA production 
↑ Bifidobacterium spp. after 6 h fermentation  
   (In vitro human fecal fermentation 24 h) 
 
Rodrigues  


















- Cellulase  
- β-glucanase 
- Ultraflo 
- Neutrase  
(Novozyme) 
Enzyme 0.5%, water,  
50°C, 3 h 
Antiviral High yield, improved biological properties 
↑ Yield (2-3-fold) 
↑ Recovery of protein, neutral sugars, uronic  
    acids, and sulphates; C. crispus (up to 3-4-fold)   
↑ Activity against Herpes simplex virus Type 1  
   - EC50 at MOI 0.001 and 0.01 ID50/cells;  
     C. fragile (1.4-folds and 2.3-fold, respectively) 
Kulshreshtha  










- Alcalase  
- Flavourzyme 
- Cellulase 
- Viscozyme L 
(Sigma-Aldrich) 
E/S ratio 50 mg: 1 g, 
water, pH 8 (Alcalase), 
pH 7 (Flavourzyme), 
and pH 4.5 (Cellulase, 






High yield, improved biological properties 
↑ Yield; C. tomentosum (up to 1.4-fold) 
↑ Antioxidant (ABTS, DPPH, Hydroxyl radical   
   Superoxide radical); S. muticum 
↑ Lactobacillus acidophilus La-5 and  
   Bifidobacterium animalis BB-12;  
   S. muticum and C. tomentosum  
  (In vitro enumeration of viable cells) 
↑ % Inhibition of α-glucosidase; 
C. tomentosum (1.4-fold) 
Rodrigues  






E/S ratio 17.8 g/kg,  
50 mM acetate buffer 
pH 5, 24°C, 320 min 
R-phycoerythrin High yield and selectivity 
↑ Yield 62-fold  
↑ Purity index up to 16-fold 





- Viscozyme L 
- Promozyme 
- Flavourzyme  
500 MG  
- Protamex  
(Novozyme) 
E/S ratio 20 mg: 1 g,  
Optimum pH and 






Reported biological properties 
- High antioxidant activity (DPPH, H2O2  
   scavenging, ferrous ion chelating, and reducing  
   power); Viscozyme and Protamex extracts  
-  High AChE inhibitory activities at 1 mg/mL;  
   Promozyme extract (93.6%) and Flavourzyme  
   extract (89.9%)  





Neutrase 0.8 L 
(Novozyme) 
E/S ratio 0.1 g: 1 g,  
0.2 M phosphate 
buffer, pH 6, 50°C, 
12 h 
 
Anticancer  Reported biological properties 
- DNA fragmentation, apoptoic body and cells;   
   Crude polysaccharide >30 kDa fraction  
 



















E/S ratio 100 µL: 1 g, 
water, pH 4.5, 50°C, 
24 h 
Anti-diabetic Reported biological properties 
- IC50: α-glucosidase 0.62 and α-amylase 0.59  
  mg/mL, Acarbose (0.68 and 0.71 mg/mL,  
  respectively) 






E/S ratio 10 µL: 1 g, 
water, 50°C, 24 h 
Fucoidan 
Anti-inflammatory 
High yield, reported biological properties 
↑ Yield (1.3-fold) 
↑ Total carbohydrate (1.4-fold) 
↑ Sulphate content (1.7-fold) 
- Inhibit nitric oxide production from  
   macrophages (RAW 264.7) 







E/S ratio 100 mg: 1 g, 
0.2 M phosphate 







Reported biological properties 
- ACE Inhibitory activity IC50 0.2 mg/mL 
- Inhibit the growth of transplanted  
   myelomonocytic leukaemia (WEHI-3) and  
   human promyelocytic leukaemia (HL-60)  
   cell lines  
- Increase DNA damage  
  (concentration >100 µg/mL) 





- AMG 300L 
- Celluclast 1.5L FG 
- Dextrozyme 





E/S ratio 20 mg: 1 g,  
Optimum pH and 





Reported biological properties 
- High total phenolic; Alcalase extract  
  (14.4 mg Gallic acid equivalent/g)  
- High total flavonoid; Celluclast extract  
  (5.1 mg Quercetin equivalent/g) 
- High antioxidant activity (DPPH, H2O2  
   scavenging, metal chelating, and reducing  
   power); Flavourzyme and Dextrozyme extracts 
- High AChE inhibitory activity at 0.25 mg/mL;  
   Flavourzyme extract (90%) and Celluclast  
   extract (60%) 
- High activity in nitrite scavenging;  






















E/S ratio 100 µg: 1 g,  
water, pH 6, 40°C,  
12 h 
Immune regulation Reported biological properties 
Increase the production of IL-2 through the 
activation of NF-κB, and induce the proliferation 
of lymphocytes with the coordinated stimulation 
of IL-2 
Ahn et al. 
(2011) 
Ecklonia cava  
(B) 
AMG 300 L 
(Novozyme) 
E/S ratio 10 µL: 1 g, 
Optimum pH and  




Improved biological properties 
↑ Prolong bleeding time at dosage of 300 µg/kg  
    (>1800 s), Control (900 s)  
Wijesinghe  
et al. (2011) 
Porphyra tenera 
(R) 
- Viscozyme L 
- Maltogenase 
- Alcalase 2.4L FG 
- Flavourzyme  
500 MG 
(Novozyme) 
E/S ratio 20 mg: 1 g,  
Optimum pH and 





Reported biological properties 
- High antioxidant activity (DPPH, H2O2  
   scavenging, ferrous ion chelating, and reducing  
   power); Alcalase and Maltogenase extracts 
-  High AChE inhibitory activities at 1 mg/mL;  
   Flavourzyme extract (99.3%) and Viscozyme  
   extract (82.7%) 
Senevirathne  







E/S ratio 50 mg: 1 g,  
water, pH 7, 50°C,  
24 h  
Antioxidant High yield, improved biological properties 
↑ Yield (2-fold)  
↑ Total phenolic (3-fold) 
↑ Antiradical power (3.5-fold) 
↑ ORAC value (4-fold) 
Wang et al. 
(2010) 

















E/S ratio 10 mg: 1 g, 
water, pH 5.5, 40°C,  
6 h 





↑ Liquefaction (1.7-fold) 
↑ Carbohydrates (3.3-fold) 
↑ Amino acids (2.1-fold) 
↑ Nitrogen (1.8-fold) 
↑ Carbon (2.2-fold) 
Le Guillard  




















E/S ratio 100 µL: 1 g, 
0.1 M sodium acetate 
buffer, pH 4.5, 50°C, 






Improved extraction time, cost-savings, and 
extraction efficiency 
↑ Phlorotannins (1.3-fold) 
↑ Antioxidant FRAP and ORAC (1.4-fold) 
- Short extraction time 5-30 min 
Charoensiddhi 
et al. (2015) 
Gracilaria 
birdiae (R) 
Proteolytic enzyme Ultrasound-assisted 
enzymatic extraction 
2 step: 0.1 M sodium 
hydroxide, 22°C; 
Sonication: 60°C, 30 
min, 60 W 
Enzyme: pH 8.0, 





High yield, improved biological properties 
↑ Total yield (15.9-fold) 
↑ Sulphated polysaccharide: sugar/sulphate (5.1),  
   Control (8.5) 
↑ Anticoagulant and antioxidant (~2-fold) 
























E/S ratio 0.2 g: 1 g, 
0.2 M dihydrogen 
phosphate/sodium 
hydroxide buffer, pH 
8.0 under ultrasound 
irradiation 45 kHz,  
50°C, 12 h  
Iodine (minerals)  High yield 
↑ Large amount of extracted iodine  
   76-96% of total iodine. 
Romaris-














Substrates Enzymes Processes Active components or activities Advantages Reference 








E/S ratio 50 mg: 1 g,  
20 mM phosphate 
buffer, pH 7, 30°C,  
24 h 
Antibacterial Selectivity, improved biological properties 
- Degree of hydrolysis (DH); Fraction >10 kDa  
  (45.4% w/w)  
↑ Antibacterial activity against Staphylococcus  
   aureus  
↓ Maximum specific growth rate at 2.5  
   mg/mL from 0.19 to 0.02 µmax/h  
Beaulieu  






- Alkaline protease 
(Danisco) 
- Flavourzyme  
(Sigma) 
Simple hydrolysis (A) 
Alkaline protease: 
E/S ratio 4 mg: 1 g,  




Start with Alkaline 
protease hydrolysis 2 
h, following to 
Flavourzyme 
hydrolysis  
E/S ratio 5 mg: 1 g,  
water, pH 7, 55°C, 4 h  





Selectivity, improved biological properties 
- Peptide A (MW 2.3 kDa) 
  Peptide AF (MW 2.3 kDa and 287 Da) 
  Control (MW >175 kDa and 52.1 kDa) 
↑ ACE inhibition IC50; Peptide A (4.5-fold) 
↑ Antioxidant ABTS and DPPH radical  
   Inhibition IC50; Peptide AF (3.7-fold and 2.1- 
   fold, respectively) 
↑ Copper-chelating activity and Antiplatelet  
    aggregation; Peptide AF (4.2-fold and 3-fold,  
    respectively)  










Enzyme 30 units,  
0.1 M sodium acetate 






Selectivity, high yield, improved biological 
properties 
↑ >50% of phenolic content and DPPH  
   scavenging  
 ↑ Anti-bacterial activity, Control = antibiotics  



















Substrates Enzymes Processes Active components or activities Advantages Reference 
Agarose 
(Sigma) 
Celluclast 1.5L  
(Novozyme) 
E/S ratio  20 mL: 1 g, 
0.05 M acetate buffer, 
pH 5, 50°C, 24 h 
Antioxidant Selectivity, reported biological properties 
- Hydrolysis yield 20.5% and low viscosity 
- High solubility up to 86.8% 
- High water and oil adsorption capacities (3.0 and 
  4.7 g/g, respectively) 
- High antioxidant activity (DPPH 24.6%, ABTS  
  83.8%, and FRAP 1.6) 












E/S ratio 50 mg: 1 g,  
pH 4.3, 55°C, 3 h 
Flavourzyme:  
E/S ratio 20 mg: 1 g, 
pH 7, 55°C, 4 h 
ACE inhibitor 
Antioxidant  
Selectivity, Improved functional properties 
↓ MW of peptides  
   (Asp, Glu, Ala, Leu) 
↑ Protein solubility 
- ACE inhibition ~45% 
- IC50: ABTS 1.01 and DPPH 0.91 g/L
 
- High copper chelating activity ~97.5% 






- Corolase PP  
(AB Enzymes) 
- Alcalase 2.4L 
 (Novozyme) 
E/S ratio 10 µL or mg: 






 Selectivity, improved biological properties 
↑ Amino acid concentration; Alcalase (3-fold)  
   and Corolase (5-fold), Low MW peptide 
↑ ACE and DPP IV inhibitory activity: IC50;  
   Alcalase (0.2 and 2.5 mg/mL, respectively) and    
   Corolase (0.3 and 1.7 mg/mL, respectively),  
   Control (>2 and >5 mg/mL, respectively) 
↑ ~50% Renin inhibition; Corolase 
↑ Antioxidant FRAP and ORAC;  















Ultra high pressure 
(UHP)-assisted 
enzymatic extraction 
Enzyme 60 mg: 1g, pH 
8, 40°C, 24 h in UHP 
unit 100 MPa  
 
Anticoagulant Selectivity, Improved biological properties 
↓ Average MW 687  kDa, Control 877 kDa 
↑ Anticoagulant activity, APTT (1.3-fold) and  
   TT (1.6-fold) 






















E/S ratio 1:10 




Antioxidant Selectivity, improved biological properties 
↑ Degree of hydrolysis (DH 25%) 
↑ Antioxidant IC50; Alkyl radical (196 µg/mL)  
   and H2O2 (96 µg/mL), Control (554 and >180  
   µg/mL, respectively)  
 
Lee et al. 
(2016) 
*E/S: Enzyme and substrate ratio; EC50: Half-maximal effective concentration; IC50: Half-maximal inhibitory concentration; MOI: Multiplicity 3 
of infection ID50/cells, ratio (virus titer)/(cell number/mL); ABTS: 2,2’-Azinobis (3-ethylbenzothiazoline-6-sulfonic aid) diammonium salt; 4 
DPPH: 2,2-diphenyl-1-picrylhydrazyl; FRAP: Ferric reducing antioxidant power; DPP: Dipeptidyl peptidase; ORAC: Oxygen radical 5 













Table 2 Studies reporting the use of seaweed-specific enzymes in the development of seaweed bioactive compounds; B, R, and G denote brown, 1 
red, and green seaweed, respectively. ↑ and ↓ means increase and decrease compared to control. 2 





Enzymatic hydrolysis of target molecules 






0.01 mg/mL of crude 
enzyme mix, pH 6-8,  




↓ Ulvan MW to 5 kDa, Control 674 kDa 
 
Coste et al. (2015) 
Gracilaria sp. (R) 








Appropriate amount of 




Selectivity, improved biological properties 
↑ >3 log cfu/mL Bifidobacterium  
   pseudolongum BCRC 14673; Gracilaria  
  oligosaccharide 
- Exhibit the decrease of Japanese                 
encephalitis virus (JEV, Beijing-1 strain) infection 
Wu et al. (2012) 
Gelidium sp.  
Gracilaria sp.  
Porphyra dentate 
(R) 











E/S ratio 250 or 500 AU: 
0.5 g, buffer solution (0.5 
M tris-HCl buffer (pH 
6.2), 1.0 M NaCl, 0.1 M 
CaCl2), 40°C, 24 h 
Prebiotic 
Oligosaccharides 
Selectivity, improved biological properties 
↑ E. faecalis BCRC13076 and L. rhamnosus  
   BCRC14068 
   (In vitro enumeration of viable cells) 




(E. coli BL21 
(DE3)) 
Appropriate amount of 





Selectivity, improved biological properties 
↑ Bifidobacteria and Lactobacilli 
   (In vitro enumeration of viable cells) 
- Resistant to enzymes of the upper  
   gastrointestinal tract 
↑ Bifidobacteria and Lactobacilli  
  (In vivo mice model) 
↓ Putrefactive microorganisms 
↑ Degrees of polymerization ↑ Prebiotic activity 

























E/S ratio 10 U: 0.5 g, 






Selectivity, improved biological properties 
↑ Bifidobacterium bifidum ATCC 29521 and  
   Bifidobacterium longum SMU 27001 
   (In vitro enumeration of viable cells) 
- Resistant to enzymes of the upper  
   gastrointestinal tract 
↑ Bifidobacteria; 13-fold for control and 4.7-fold  
   for FOS, Lactobacilli; 5-fold for control  
    (In vivo mice model) 
↓ Enterobacteriaceae and Enterococci 
Wang et al. 
(2006) 
Enzyme-assisted extraction intensified with other processes 







Enzyme pre-treatment:  
Enzyme 0.05% (w/w of 
dried seaweed),  
water pH 6.2, 37°C, 2 h  
Supercritical fluid 
extraction: 
Dimethyl ether extraction 
with ethanol co-solvent, 
60°C, 40 bar 
Fucoxanthin 





High yield, cost-saving 
↑ Fucoxanthin 1.1-fold 
↑ Lipids rich in PUFAs 1.3-fold 
Billakanti  
















Table 3 Quality criteria and regulations applied to seaweeds and their products  1 
Risk items 
Upper limit  
Australia France USA EU 
Toxic minerals 
(mg/kg DW, ppm) 
 
















































- Fecal coliforms 
- Clostridium perfringens 











- FSANZ (2013) 
- FSANZ (2010)  
- CEVA (2014) 
- Mabeau and Fleurence   
  (1993) 
Mabeau and Fleurence    
(1993) 
- Holdt and Kraan (2011) 






















































• Seaweeds are important source of bioactive compounds for prebiotic and nutraceutical. 
• Enzyme extraction and hydrolysis are valuable to produce seaweed bioactive compounds. 
• Enzyme processes improve the value of seaweeds and broaden their food applications. 
• Enzymes with activities specific to seaweed improve hydrolysis and functionality. 
• Food safety focus of seaweed consumption on heavy metals and iodine. 
 
 
  
